VANGUARD GROUP INC

Holdings History for Tonix Pharmaceuticals Holding Corp. - Common Stock (TNXP)

Symbol: TNXP on Nasdaq
Investment type: Equity / Common Stock
Latest Disclosed Shares Owned: 673,605 shares
Security Ownership %: 5%

Shares, Excluding Options vs Price

Value, Excluding Options

The Vanguard Group ownership in Tonix Pharmaceuticals Holding Corp. Common Stock (TNXP)

30 Jan 2026 - The Vanguard Group has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 673,605 shares of Tonix Pharmaceuticals Holding Corp. Common Stock (TNXP). This represents 5% ownership of the company. In their previous filing dated 31 Oct 2025, VANGUARD GROUP INC had reported owning 556,957 shares, indicating an increase of +21%. .

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
The Vanguard Group	5%	-22%	$10,521,710	673,605	+116,648	+21%	$15.62	13G/A	31 Dec 2025	30 Jan 2026, 14:45
The Vanguard Group	6.4%		$13,456,081	556,957			$24.16	13G	30 Sep 2025	31 Oct 2025, 11:31

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$10,521,710	673,605	+116,648	+21%	$15.62	Q4 2025
30 Sep 2025	0%	+0%	$13,456,081	556,957	+392,225	+238%	$24.16	Q3 2025
30 Jun 2025	0%	+0%	$5,927,057	164,732	+73,236	+80%	$35.98	Q2 2025
31 Mar 2025	0%	+0%	$1,635,491	91,496	+91,496	NEW	$17.88	Q1 2025

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.